Intl. VTE & Cancer Guidelines
Based on international guidelines published in 2013, this app is a practical, step-by-step guide for the prophylaxis and treatment of venous thromboembolism in patients with cancer, including:• Prophylaxis in hospitalized and ambulatory patients• Treatment guidance for both non-catheter and catheter-related VTE• Specific guidance related to various cancer and treatment types• Early, short-term, and long-term treatment guidance
This treatment algorithm is intended for physicians and other healthcare professionals treating patients with cancer. It should not replace clinical judgement. It is based on two clinical practice guidelines published in 2013:1. Farge D, Debourdeau P, Beckers M, Baglin C, Bauersachs RM, Brenner B, Brilhante D, Falanga A, Gerotzafias GT, Haim N, Kakkar AK, Khorana AA, Lecumberri R, Mandala M, Marty M, Monreal M, Mousa SA, Noble S, Pabinger I, Prandoni P, Prins MH, Qari MH, Streiff MB, Syrigos K, Bounameaux H, Büller HR. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost. 2013;11(1):56-70.2. Debourdeau P, Farge D, Beckers M, Baglin C, Bauersachs RM, Brenner B, Brilhante D, Falanga A, Gerotzafias GT, Haim N, Kakkar AK, Khorana AA, Lecumberri R, Mandala M, Marty M, Monreal M, Mousa SA, Noble S, Pabinger I, Prandoni P, Prins MH, Qari MH, Streiff MB, Syrigos K, Büller HR, Bounameaux H. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer. J Thromb Haemost. 2013;11(1):71-80.
While these guidelines rely on the best available evidence at the time of publication, the clinician is advised to use clinical judgement when making decisions about prophylaxis and treatment of venous thromboembolism in patients with cancer.
APP AUTHORS / STEERING COMMITTEEProfessor Dominique Farge (France) (Co-chairperson)Dr Philippe Debourdeau (France) (Co-chairperson)Professor Henri Bounameaux (Switzerland)Professor Benjamin Brenner (Israel)Right Honorable Professor Lord Ajay Kakkar (United Kingdom)Professor Ingrid Pabinger-Fasching (Austria)Dr Michael Streiff (United States)
ABOUT ITAC-CMEThe International Initiative on Thrombosis and Cancer (ITAC-CME) is the international section of the Groupe Francophone Thrombose et Cancer (GFTC). A multidisciplinary group, the members of ITAC-CME are clinicians and researchers from across the globe, led by a core group of GFTC members. The mandate of ITAC-CME is to publish results of educational knowledge transfer research findings.
Through education of physicians, nurses, and allied health professionals, ITAC-CME is committed to disseminating relevant and peer-reviewed prophylaxis and treatment guidelines for VTE in cancer that will help to reduce a substantial economic burden on health care systems and improve the lives of millions of patients worldwide.
This treatment algorithm is intended for physicians and other healthcare professionals treating patients with cancer. It should not replace clinical judgement. It is based on two clinical practice guidelines published in 2013:1. Farge D, Debourdeau P, Beckers M, Baglin C, Bauersachs RM, Brenner B, Brilhante D, Falanga A, Gerotzafias GT, Haim N, Kakkar AK, Khorana AA, Lecumberri R, Mandala M, Marty M, Monreal M, Mousa SA, Noble S, Pabinger I, Prandoni P, Prins MH, Qari MH, Streiff MB, Syrigos K, Bounameaux H, Büller HR. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost. 2013;11(1):56-70.2. Debourdeau P, Farge D, Beckers M, Baglin C, Bauersachs RM, Brenner B, Brilhante D, Falanga A, Gerotzafias GT, Haim N, Kakkar AK, Khorana AA, Lecumberri R, Mandala M, Marty M, Monreal M, Mousa SA, Noble S, Pabinger I, Prandoni P, Prins MH, Qari MH, Streiff MB, Syrigos K, Büller HR, Bounameaux H. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer. J Thromb Haemost. 2013;11(1):71-80.
While these guidelines rely on the best available evidence at the time of publication, the clinician is advised to use clinical judgement when making decisions about prophylaxis and treatment of venous thromboembolism in patients with cancer.
APP AUTHORS / STEERING COMMITTEEProfessor Dominique Farge (France) (Co-chairperson)Dr Philippe Debourdeau (France) (Co-chairperson)Professor Henri Bounameaux (Switzerland)Professor Benjamin Brenner (Israel)Right Honorable Professor Lord Ajay Kakkar (United Kingdom)Professor Ingrid Pabinger-Fasching (Austria)Dr Michael Streiff (United States)
ABOUT ITAC-CMEThe International Initiative on Thrombosis and Cancer (ITAC-CME) is the international section of the Groupe Francophone Thrombose et Cancer (GFTC). A multidisciplinary group, the members of ITAC-CME are clinicians and researchers from across the globe, led by a core group of GFTC members. The mandate of ITAC-CME is to publish results of educational knowledge transfer research findings.
Through education of physicians, nurses, and allied health professionals, ITAC-CME is committed to disseminating relevant and peer-reviewed prophylaxis and treatment guidelines for VTE in cancer that will help to reduce a substantial economic burden on health care systems and improve the lives of millions of patients worldwide.
Category : Medical
Related searches